Landscape of BRAF transcript variants in human cancer
We investigate the annotation of BRAF variants, focusing on protein‐coding BRAF‐220 (formerly BRAF‐reference) and BRAF‐204 (BRAF‐X1). The IsoWorm pipeline allows us to quantify these variants in human cancer, starting from RNA‐sequencing data. BRAF‐204 is more abundant than BRAF‐220 and impacts patient survival.
Maurizio S. Podda+5 more
wiley +1 more source
Case Report: Clinical presentations of cyanosis associated with acquired methemoglobinemia in infants-a clinical challenge. [PDF]
Wang L+7 more
europepmc +1 more source
Loss of proton‐sensing GPR4 reduces tumor progression in mouse models of colon cancer
G protein‐coupled receptor 4 (GPR4) is a pH‐sensing receptor activated by acidic pH. GPR4 expression is increased in patients with inflammatory bowel disease who are at high risk of developing colorectal cancer. In mouse models, loss of GPR4 attenuated tumor progression. This correlated with increased IL2 and natural killer cell activity.
Leonie Perren+16 more
wiley +1 more source
Acquired epidermodysplasia verruciformis secondary to methotrexate
Mohammed A. AlFada, MD, MBA+1 more
doaj
Acute Intestinal Obstruction in Infancy and Childhood: Congenital Abnormalities: Acquired Causes: Treatment [PDF]
Alastair H. MacLennan
openalex +1 more source
TRPM8 levels determine tumor vulnerability to channel agonists
TRPM8 is a Ca2+ permissive channel. Regardless of the amount of its transcript, high levels of TRPM8 protein mark different tumors, including prostate, breast, colorectal, and lung carcinomas. Targeting TRPM8 with channel agonists stimulates inward calcium currents followed by emptying of cytosolic Ca2+ stores in cancer cells.
Alessandro Alaimo+18 more
wiley +1 more source
Physician mergers involve 38% of doctors, substantial health system participation, and frequent serial acquisition. [PDF]
Deibler D, Hosken D, Koch T, Thomas M.
europepmc +1 more source
Experimental Study of Acquired Resistance of the Rabbit's Renal Epithelium to Mercuric Chloride [PDF]
Warren C. Hunter
openalex +1 more source
Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitors
D. Westover+4 more
semanticscholar +1 more source